aluates Reports

$ 0.0

Automative

Global Sitagliptin Metformin Extended Release Tablets Market Research Report 2026

Published Date: 2026-02-05

Report Code: QYRE-Auto-2L18402

Global Sitagliptin Metformin Extended Release Tablets Market Research Report 2024

BUY CHAPTERS

Global Sitagliptin Metformin Extended Release Tablets Market Research Report 2026

Code: QYRE-Auto-2L18402

Report

2026-02-05

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Jiangsu Xuantai Pharmaceutical Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group

Merck& Co. Inc

Abbott

Sandoz Inc

Jiangsu Anbisheng Pharmaceutical Co., Ltd.

Sitagliptin Metformin Extended Release Tablets Market

The global Sitagliptin Metformin Extended Release Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sitagliptin Metformin Extended Release Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Sitagliptin Metformin Extended Release Tablets is a combination drug used to treat type 2 diabetes. Through the synergistic effect of sitagliptin and metformin, it helps patients better control blood sugar levels. This drug is suitable for patients who have poor blood sugar control through diet and exercise. It can lower blood sugar and improve insulin resistance through different mechanisms.

The North American market for Sitagliptin Metformin Extended Release Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Sitagliptin Metformin Extended Release Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Sitagliptin Metformin Extended Release Tablets include Jiangsu Anbisheng Pharmaceutical Co., Ltd., Jiangsu Xuantai Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group, Merck & Co., Inc., Abbott, Sandoz Pty Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Sitagliptin Metformin Extended Release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sitagliptin Metformin Extended Release Tablets. The Sitagliptin Metformin Extended Release Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sitagliptin Metformin Extended Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sitagliptin Metformin Extended Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sitagliptin Metformin Extended Release Tablets Market Report

Report Metric	Details
Report Name	Sitagliptin Metformin Extended Release Tablets Market
Segment by Type	Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Jiangsu Anbisheng Pharmaceutical Co., Ltd., Jiangsu Xuantai Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group, Merck & Co., Inc., Abbott, Sandoz Pty Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sitagliptin Metformin Extended Release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sitagliptin Metformin Extended Release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Sitagliptin Metformin Extended Release Tablets Market report?

Ans: The main players in the Sitagliptin Metformin Extended Release Tablets Market are Jiangsu Anbisheng Pharmaceutical Co., Ltd., Jiangsu Xuantai Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group, Merck & Co., Inc., Abbott, Sandoz Pty Ltd

What are the Application segmentation covered in the Sitagliptin Metformin Extended Release Tablets Market report?

Ans: The Applications covered in the Sitagliptin Metformin Extended Release Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Sitagliptin Metformin Extended Release Tablets Market report?

Ans: The Types covered in the Sitagliptin Metformin Extended Release Tablets Market report are Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg, Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg

1 Sitagliptin Metformin Extended Release Tablets Market Overview

1.1 Product Definition

1.2 Sitagliptin Metformin Extended Release Tablets by Type

1.2.1 Global Sitagliptin Metformin Extended Release Tablets Market Value by Type: 2025 vs 2032

1.2.2 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg

1.2.3 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg

1.3 Sitagliptin Metformin Extended Release Tablets by Application

1.3.1 Global Sitagliptin Metformin Extended Release Tablets Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Sitagliptin Metformin Extended Release Tablets Market Size Estimates and Forecasts

1.4.1 Global Sitagliptin Metformin Extended Release Tablets Revenue 2021–2032

1.4.2 Global Sitagliptin Metformin Extended Release Tablets Sales 2021–2032

1.4.3 Global Sitagliptin Metformin Extended Release Tablets Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Sitagliptin Metformin Extended Release Tablets Market Competition by Manufacturers

2.1 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)

2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Sitagliptin Metformin Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Product Types and Applications

2.7 Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Date of Entry into the Industry

2.8 Global Sitagliptin Metformin Extended Release Tablets Market Competitive Situation and Trends

2.8.1 Global Sitagliptin Metformin Extended Release Tablets Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Sitagliptin Metformin Extended Release Tablets Players Market Share by Revenue

2.8.3 Global Sitagliptin Metformin Extended Release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sitagliptin Metformin Extended Release Tablets Market Scenario by Region

3.1 Global Sitagliptin Metformin Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021–2032

3.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021–2026

3.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2027–2032

3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021–2032

3.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021–2026

3.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2027–2032

3.4 North America Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country

3.4.1 North America Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)

3.4.3 North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country

3.5.1 Europe Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)

3.5.3 Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Sitagliptin Metformin Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (2021–2032)

3.6.3 Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country

3.7.1 Latin America Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)

3.7.3 Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2021–2032)

3.8.3 Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021–2032)

4.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021–2026)

4.1.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2027–2032)

4.1.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021–2032)

4.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021–2032)

4.2.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021–2026)

4.2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2027–2032)

4.2.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021–2032)

4.3 Global Sitagliptin Metformin Extended Release Tablets Price by Type (2021–2032)

5 Segment by Application

5.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021–2032)

5.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021–2026)

5.1.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2027–2032)

5.1.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021–2032)

5.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021–2032)

5.2.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021–2026)

5.2.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2027–2032)

5.2.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021–2032)

5.3 Global Sitagliptin Metformin Extended Release Tablets Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd.

6.1.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information

6.1.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Description and Business Overview

6.1.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio

6.1.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates

6.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.

6.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information

6.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview

6.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio

6.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates

6.3 Chia Tai Tianqing Pharmaceutical Group

6.3.1 Chia Tai Tianqing Pharmaceutical Group Company Information

6.3.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview

6.3.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product Portfolio

6.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates

6.4 Merck & Co., Inc.

6.4.1 Merck & Co., Inc. Company Information

6.4.2 Merck & Co., Inc. Description and Business Overview

6.4.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product Portfolio

6.4.5 Merck & Co., Inc. Recent Developments/Updates

6.5 Abbott

6.5.1 Abbott Company Information

6.5.2 Abbott Description and Business Overview

6.5.3 Abbott Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Abbott Sitagliptin Metformin Extended Release Tablets Product Portfolio

6.5.5 Abbott Recent Developments/Updates

6.6 Sandoz Pty Ltd

6.6.1 Sandoz Pty Ltd Company Information

6.6.2 Sandoz Pty Ltd Description and Business Overview

6.6.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product Portfolio

6.6.5 Sandoz Pty Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sitagliptin Metformin Extended Release Tablets Industry Chain Analysis

7.2 Sitagliptin Metformin Extended Release Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sitagliptin Metformin Extended Release Tablets Production Mode & Process Analysis

7.4 Sitagliptin Metformin Extended Release Tablets Sales and Marketing

7.4.1 Sitagliptin Metformin Extended Release Tablets Sales Channels

7.4.2 Sitagliptin Metformin Extended Release Tablets Distributors

7.5 Sitagliptin Metformin Extended Release Tablets Customer Analysis

8 Sitagliptin Metformin Extended Release Tablets Market Dynamics

8.1 Sitagliptin Metformin Extended Release Tablets Industry Trends

8.2 Sitagliptin Metformin Extended Release Tablets Market Drivers

8.3 Sitagliptin Metformin Extended Release Tablets Market Challenges

8.4 Sitagliptin Metformin Extended Release Tablets Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Jiangsu Xuantai Pharmaceutical Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group

Merck& Co. Inc

Abbott

Sandoz Inc

Jiangsu Anbisheng Pharmaceutical Co., Ltd.

List of Tables

Table 1. Global Sitagliptin Metformin Extended Release Tablets Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Sitagliptin Metformin Extended Release Tablets Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Sitagliptin Metformin Extended Release Tablets Market Competitive Situation by Manufacturers in 2025

Table 4. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Sitagliptin Metformin Extended Release Tablets Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Sitagliptin Metformin Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Product Types and Applications

Table 12. Global Key Manufacturers of Sitagliptin Metformin Extended Release Tablets, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sitagliptin Metformin Extended Release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sitagliptin Metformin Extended Release Tablets Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sitagliptin Metformin Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2021–2026

Table 18. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021–2026)

Table 19. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2027–2032

Table 20. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2027–2032)

Table 21. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2021–2026

Table 22. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021–2026)

Table 23. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2027–2032

Table 24. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2027–2032)

Table 25. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026

Table 27. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032

Table 28. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026

Table 29. North America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026

Table 32. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032

Table 33. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026

Table 42. Latin America Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032

Table 43. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue by Country (US$ Million), 2027–2032

Table 50. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Type (2021–2026)

Table 51. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Type (2027–2032)

Table 52. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021–2026)

Table 53. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2027–2032)

Table 54. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021–2026)

Table 57. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2027–2032)

Table 58. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2021–2026)

Table 59. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2027–2032)

Table 60. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Application (2021–2026)

Table 61. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units) by Application (2027–2032)

Table 62. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021–2026)

Table 63. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2027–2032)

Table 64. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Sitagliptin Metformin Extended Release Tablets Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021–2026)

Table 67. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2027–2032)

Table 68. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2021–2026)

Table 69. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2027–2032)

Table 70. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information

Table 71. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Description and Business Overview

Table 72. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product

Table 74. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 75. Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information

Table 76. Jiangsu Xuantai Pharmaceutical Co., Ltd. Description and Business Overview

Table 77. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product

Table 79. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 80. Chia Tai Tianqing Pharmaceutical Group Company Information

Table 81. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview

Table 82. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product

Table 84. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates

Table 85. Merck & Co., Inc. Company Information

Table 86. Merck & Co., Inc. Description and Business Overview

Table 87. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product

Table 89. Merck & Co., Inc. Recent Developments/Updates

Table 90. Abbott Company Information

Table 91. Abbott Description and Business Overview

Table 92. Abbott Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Abbott Sitagliptin Metformin Extended Release Tablets Product

Table 94. Abbott Recent Developments/Updates

Table 95. Sandoz Pty Ltd Company Information

Table 96. Sandoz Pty Ltd Description and Business Overview

Table 97. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product

Table 99. Sandoz Pty Ltd Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Sitagliptin Metformin Extended Release Tablets Distributors List

Table 103. Sitagliptin Metformin Extended Release Tablets Customers List

Table 104. Sitagliptin Metformin Extended Release Tablets Market Trends

Table 105. Sitagliptin Metformin Extended Release Tablets Market Drivers

Table 106. Sitagliptin Metformin Extended Release Tablets Market Challenges

Table 107. Sitagliptin Metformin Extended Release Tablets Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sitagliptin Metformin Extended Release Tablets

Figure 2. Global Sitagliptin Metformin Extended Release Tablets Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Sitagliptin Metformin Extended Release Tablets Market Share by Type: 2025 & 2032

Figure 4. Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Product Picture

Figure 5. Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg Product Picture

Figure 6. Global Sitagliptin Metformin Extended Release Tablets Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Sitagliptin Metformin Extended Release Tablets Market Share by Application: 2025 & 2032

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Sitagliptin Metformin Extended Release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Sitagliptin Metformin Extended Release Tablets Market Size (US$ Million), 2021–2032

Figure 13. Global Sitagliptin Metformin Extended Release Tablets Sales (K Units), 2021–2032

Figure 14. Global Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit), 2021–2032

Figure 15. Sitagliptin Metformin Extended Release Tablets Report Years Considered

Figure 16. Sitagliptin Metformin Extended Release Tablets Sales Share by Manufacturers in 2025

Figure 17. Global Sitagliptin Metformin Extended Release Tablets Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Sitagliptin Metformin Extended Release Tablets Players: Market Share by Revenue in Sitagliptin Metformin Extended Release Tablets in 2025

Figure 19. Sitagliptin Metformin Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Sitagliptin Metformin Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)

Figure 22. North America Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)

Figure 23. United States Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)

Figure 26. Europe Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)

Figure 27. Germany Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021–2032)

Figure 34. China Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. China Taiwan Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Southeast Asia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Latin America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)

Figure 42. Latin America Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)

Figure 43. Mexico Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Brazil Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Argentina Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Colombia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Sitagliptin Metformin Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Sitagliptin Metformin Extended Release Tablets by Type (2021–2032)

Figure 53. Global Revenue Market Share of Sitagliptin Metformin Extended Release Tablets by Type (2021–2032)

Figure 54. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Type (2021–2032)

Figure 55. Global Sales Market Share of Sitagliptin Metformin Extended Release Tablets by Application (2021–2032)

Figure 56. Global Revenue Market Share of Sitagliptin Metformin Extended Release Tablets by Application (2021–2032)

Figure 57. Global Sitagliptin Metformin Extended Release Tablets Price (US$/Unit) by Application (2021–2032)

Figure 58. Sitagliptin Metformin Extended Release Tablets Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions